Tag Archives: Psoriasis

Biocon receives marketing authorization for novel biologic Itolizumab

Biocon, Asia’s premier biotechnology company today announced that it has received Marketing Authorization from the Drugs Controller General of India DCGI for its Novel Biologic Itolizumab, anti CD6 molecule, for the treatment of chronic plaque Psoriasis.

Itolizumab, is a first in class therapy with a unique Mechanism of Action (MOA) and an excellent safety profile as indicated during the 52 week Phase III multi-centric clinical study conducted in India. It is the second Novel Biologic developed by Biocon at Asia’s largest Biotech hub in Bangalore.

This approval paves the way for the launch of Biocon’s Alzumab in India, later during 2013. Alzumab™ is a differentiated biologic drug with a superior safety profile compared to other approved biologic therapies given its very low opportunistic infection rates. A novel biologic indicated for the treatment of Mode rate-to-Severe Psoriasis, Alzumab™ will be marketed by Biocon’s Immunotherapy Division. Alzumab™, will be manufactured and formulated as an infusion drug at Biocon’s Biopharma manufacturing facility at Biocon Park, Bangalore.

Article Source: http://modernpharma.in/news/biocon-receives-marketing-authorization-for-novel-biologic-itolizumab/2905.html

Psoriasis Treatment

Study Finds Links Between Psoriasis, Heart Failure

People with the skin disorder psoriasis might be at higher risk for heart failure and should be screened for heart disease, experts say.

Researchers looked at medical data on all adults in Denmark. They found that people with psoriasis are more prone to develop heart failure and that the risk of heart failure rises as psoriasis gets more severe.

“Our findings underline the importance of regular evaluation and treatment of cardiovascular risk factors in patients with psoriasis,” said study lead author Dr. Usman Khalid. Chronic inflammation — a component of both heart failure and psoriasis — may be the link between the two, he added.

Psoriasis affects 125 million people worldwide. It is a lifelong disorder that causes red, scaly patches on the skin.

“Psoriasis should be considered a systemic inflammatory disease that affects the whole body, rather than an isolated skin lesion,” Khalid explained. “Clinicians should consider early screening and treatment of cardiovascular risk factors in patients with psoriasis — such as obesity, smoking and a sedentary lifestyle — in order to reduce the long-term risk of cardiovascular disease and death.”

Educating patients with psoriasis about the association between their skin condition and heart disease is key to encouraging them to adopt heart healthy behaviors, Khalid added.

The study was presented at a recent European Society of Cardiology meeting in Amsterdam. Findings presented at meetings typically are considered preliminary until published in a peer-reviewed medical journal.

Although the research found an association between psoriasis and increased risk for heart failure, it did not necessarily prove a cause-and-effect relationship.

Article Source: http://news.health.com/2013/11/01/study-finds-links-between-psoriasis-heart-failure/

Blog Source: http://news.health.com/category/psoriasis/

Herose Treatment on Psoriasis: www.herosepharma.com

Women and Psoriasis

Treating psoriasis and psoriatic arthritis in women requires extra considerations. If you are planning to become pregnant, you may wonder how Psoriasis could affect you and your baby. If you are nursing, you may have questions about the safety of treatments.

Studies also show that the emotional and social effects of psoriasis and psoriatic arthritis are more significant for women than men.

Article Source: http://www.psoriasis.org/about-psoriasis/women-and-psoriasis

More Information: http://www.psoriasis.org/about-psoriasis/resources

Psoriasis – Related Medindia Resources

Psoriasis is a complex, inflammatory disease which mostly affects the skin and joints. It is however not a contagious disease.

The disease affects both males and females of all age group. Nevertheless it mostly makes its mark for the first time in young individuals between the age of 15-20 years.It is quite unusual for the disease to manifest before the age of 5 years.

The incidence of psoriasis in the western populance is between 2-3% . There are more than 5 million Americans who have psoriasis, and it is estimated that the burden of the disease costs $1.6 to $3.2. billion each year ( National Psoriasis Foundation).

Every year 150,000 and 260,000 new cases are diagnosed and this includes 20,000 in children who are younger than 10 years.

“This disease is common, chronic, and costly, both in monetary terms and in quality of life,” says Jonathan Wilkin, M.D., Director of the FDA’s Division of Dermatologic and Dental Drug Products. The incidence of the disease is quite low in some populations,like the Japanese.

According to a study in India, 60% of the patients had the disease onset before the age of 30 years, with a positive family history in almost 14% of the cases. Skin and scalp were the most commonly affected site.

The inheritance of psoriasis does not fit into the Mendelian pattern. When one parent has the disease the chances of the child to develop the disease is 15-20% ; if both parents have the disease, the chances of the child getting the disease is 50 percent.

One of the longest known illness, psoriasis is also one of the most misunderstood, as it was often confused with leprosy.

In 1841 a Viennese dermatologist Ferdinand Von Hebra assigned the word ‘Psoriasis’ to this disease. The word was coined from the Greek word ‘psora’-meaning ‘to itch’.

Plaque psoariasis or psoriasis vulgaris is the the most common form of the disease. There are typically, red scaly patches – called psoriatic plaques that appear on the skin of affected persons. These plaques are inflammatory sites where the skin rapidly accumulates, thereby, taking on a silvery white appearance. When the scales are removed, the skin underneath is tender and tends to bleed and results in the inflamed patches.

In the case of a normal skin, the production and proliferation of the epidermal layer of the skin takes about 28 days to complete, while in the case of psoriasis, it is restricted to just 4 days.This results in the pile up of immature skin cells – a special feature charecteristic to psoriatic lesion .

The severity with which psoriasis occur varies.The plaques may occur as local patches or they may be distributed all over the body.They frequently affect the skin covering the elbows and knees but may also occur on the scalp, finger or toe nails or on the genital area. In some cases, it may cause psoriatic arthritis or inflammation of the joints.This condition is observed in 10-15% of psoriasis patients.

The pathogenesis of psoriasis is yet unknown but it is believed to be immune-mediated.Genes may play a role in its development.

The psychological impact of the disease is inevitable because of the unattractive skin manifestations.Most often the patients are depressed and suffer from very low self-esteem. As such, their lifestyle becomes compromised.

Psoriasis Treatment continues to be a challenge due to the recurrent nature of the disease. There is no cure for the disease.

Disease management will be dependant on its severity, its impact on the patient and also on the patient’s lifestyle.Those involved in the care of psoriatic patients must be skilled in the art of disease management and must also be capable of motivating the patient.

Article Source: http://www.medindia.net/patients/patientinfo/Psoriasis.htm

More Resources: http://www.medindia.net/health-resources/psoriasis.htm

What is Psoriasis and how it affects you?

Psoriasis is a chronic, recurring, non-contagious skin disorder that is characterized by raised, thickened reddish patches on the skin covered with silvery-white scales that may vary in severity and affect any part of the body, including the nails, scalp and the genital region. There are about 125 million psoriasis sufferers world wide. This makes up 3% of the world’s total population! It is estimated that six to seven million Americans have psoriasis, and each year 150,000 to 260,000 new cases are diagnosed.

The incidence of psoriasis is much lower in dark-skinned West Africans and African-Americans than in light-skinned persons of European origin. Incidence is also low in the Eskimos and the Japanese, and is extremely rare in Native Americans. Genetic, geographic and environmental factors may play a major role in this striking disparity between the races.

Most psoriasis patients undergo intense emotional turmoil while they fight to control their disease which tends to have periods of flare ups and remissions the year around. Though no cure has yet been discovered, observing certain principles in life style and skin care management will provide patients a scope for optimum control of the disease.

Check out our website for more information www.herosepharma.com

Article Source: http://EzineArticles.com/338332